- Scientists 'Gleeful' About Clinical Trial Of MediciNova's Treatment For Methamphetamine Addiction
- MediciNova Surges:Time To Buy Later -- After New Stock Issue
- Time To Dump Diluted Shares Of Trius - Or Double Down?
- Glaxo's Genital Herpes Vaccine Flops But Genocea's Next-Generation Approach Makes It A Buy
- Why Buy Vivus And Arena? Private Insurance, ObamaCare To Cover Their Obesity Drugs
This user currently has no profile.
I’m CEO of San Diego Biotechnology Connection (https://sandiegobiotechnology.com). I have a M.S. degree (microbiology) from the University of Iowa and completed a one-year science journalism fellowship at MIT. I have been an award-winning science writer and editor for 30 years for newspapers, magazines and research institutes and I have won numerous awards from state medical societies, state Associated Press Managing Editors associations, the American College of Emergency Physicians and a Silver Gavel Award from the American Bar Association. I was senior director of communications for UC San Diego prior to founding San Diego Biotechnology Connection.
- Description: Newsletter author. Trading frequency: Weekly
- Interests: Stocks - long, Tech stocks
San Diego Biotechnology Connection I provide objective news and analysis highlighting the San Diego biotech sector. Our site also provides job listings (http://sandiegobiotechnology.com/biotech-jobs/) and a job-posting site for biotech enterprises and recruiters seeking the best and brightest applicants.
San Diego Biotechnology Connection My passionate curiosity as a communicator and science journalist is the driving force behind San Diego Biotechnology Connection. The company’s website, monthly newsletter and social media channels are designed to provide the San Diego biotech sector with news about their milestones, successes and job ...More
postings. Additional services that our team provides to industry and academic clients in the biotech sector include savvy project-based communications and PR services, third-party stories that explain the hard-to-explain, video-production services, and, for organizers of biotech-related conferences in San Diego, a suite of news, advertising and communications services designed to enhance their events.
Currently, you have no book details. Click edit to add book details.
Latest Comments more »
- I can only hope the analyst... on BofA note spooks Amgen, Ligand investors
- Speaking of methamphetamine... on Acura Pharmaceuticals Reaches Key Milestone Wit...
- A lot has happened since th... on FDA Grants Fast Track Designation for MediciNov...
- I talked to the lead resear... on UCLA Presents Data on MediciNova's MN-166 in Me...
- Good analysis of the cash M... on Secretive Dilution And A Possible Equity Financ...
Latest comments on Rex's Articles
- SpacyRo on Glaxo's Genital Herpes Vaccine Flops But Genoce...
- Rex Graham on Time To Dump Diluted Shares Of Trius - Or Doubl...
- glider549 on Time To Dump Diluted Shares Of Trius - Or Doubl...
- itchibahn on Time To Dump Diluted Shares Of Trius - Or Doubl...
- Fox333 on Time To Dump Diluted Shares Of Trius - Or Doubl...
LATEST ARTICLES & INSTAPOSTS more »